io103,pembrolizumab,io102
merck,io biotech
['melanoma', 'iobiotech']
are you attending this year s #2022congress in edinburgh, u.k.? check out our cmo eva ehrnrooth, m.d., ph.d., who will be presenting a trials in progress poster on our phase 3 global trial in #melanoma. click for more details: 
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer.